A35-009 (ORION) is a Phase 2b/3 trial to evaluate the efficacy and safety of AMX0035 in participants with Progressive Supranuclear Palsy (PSP), consisting of randomized, double blind placebo controlled phases, followed by an optional open-label鈥�
- Investigator
- Nikolaus McFarland
- Ages
- 40 Years - 80 Years
- Sexes
- All